IM Therapeutics Spins Out of University of Colorado to Focus on Type 1 Diabetes Post author:Sam Post published:November 9, 2017 Post category:BioPharma ImmunoMolecular Therapeputics officially launched yesterday. Source: BioSpace You Might Also Like Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017 FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed September 24, 2017 Life Science Community Comes Together to Support Rare Disease Day February 27, 2018
Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and… December 5, 2017
